Publications searcher

The science produced by our scientists is very important. In 2022, 1,629 papers were published in scientific journals with a global impact factor of over 15,000 points.

Nurses' knowledge of evidence-based guidelines for the prevention of surgical site infection.

PMID: 19919658
Journal: Worldviews on Evidence-Based Nursing
Year: 2010
Reference: Worldviews Evid Based Nurs. 2010 Mar;7(1):16-24. Epub 2009 Nov 16.
Impact factor: 1.944
Publication type: Paper in international publication
Authors: Labeau, Sonia O, Witdouck, Stijn S, Vandijck, Dominique M, Claes, Brigitte, Rello, Jordi, Vandewoude, Koenraad H, Lizy, Christelle M, Vogelaers, Dirk P, Blot, Stijn I et al.
DOI: 10.1111/j.1741-6787.2009.00177.x

Nurses' knowledge of evidence-based guidelines for the prevention of surgical site infection.

PMID: 19919658
Journal: Worldviews on Evidence-Based Nursing
Year: 2010
Reference: Worldviews Evid Based Nurs. 2010 Mar;7(1):16-24. Epub 2009 Nov 16.
Impact factor:
Publication type: Paper in international publication
Authors: Blot, Stijn I; Claes, Brigitte; Labeau, Sonia O; Lizy, Christelle M; Rello, Jordi; Vandewoude, Koenraad H; Vandijck, Dominique M; Vogelaers, Dirk P; Witdouck, Stijn S et al.
DOI: 10.1111/j.1741-6787.2009.00177.x

[Nursing role in patient management diagnosed chronic fatigue syndrome].

PMID: 21322185
Journal: Rev Enferm
Year: 2010
Reference: Rev Enferm. 2010 Dec;33(12):20-7.
Impact factor:
Publication type: Letter or abstract
Authors: Alvarez, Carballo, Royes, Badia, Lalinde, Sevillano, Vidal, Llinas, Martin, Alegre et al.
DOI:

[Nursing role in patient management diagnosed chronic fatigue syndrome].

PMID: 21322185
Journal: Revista de enfermeria (Barcelona, Spain)
Year: 2010
Reference: Rev Enferm. 2010 Dec;33(12):20-7.
Impact factor:
Publication type: Letter or abstract
Authors: Alvarez, Carballo; Lalinde, Sevillano; Martin, Alegre; Royes, Badia; Vidal, Llinas et al.
DOI:

Obstructive sleep apnoea and 24-h blood pressure in patients with resistant hypertension.

PMID: 20545837
Journal: JOURNAL OF SLEEP RESEARCH
Year: 2010
Reference: J Sleep Res. 2010 Dec;19(4):597-602. doi: 10.1111/j.1365-2869.2010.00839.x.
Impact factor: 3.5
Publication type: Paper in international publication
Authors: , , , , , , , et al.
DOI: 10.1111/j.1365-2869.2010.00839.x

Obstructive sleep apnoea and 24-h blood pressure in patients with resistant hypertension.

PMID: 20545837
Journal: JOURNAL OF SLEEP RESEARCH
Year: 2010
Reference: J Sleep Res. 2010 Dec;19(4):597-602. doi: 10.1111/j.1365-2869.2010.00839.x.
Impact factor:
Publication type: Paper in international publication
Authors: ; ; ; ; ; ; ; et al.
DOI: 10.1111/j.1365-2869.2010.00839.x

Occupational asthma due to colistin in a pharmaceutical worker.

PMID: 20442121
Journal: CHEST
Year: 2010
Reference: Chest. 2010 May;137(5):1200-2.
Impact factor: 6.36
Publication type: Paper in international publication
Authors: Gomez-Olles, Susana, Madrid-San Martin, Federico, Cruz, Maria-Jesus, Munoz, Xavier et al.
DOI: 10.1378/chest.09-1881

Occupational asthma due to colistin in a pharmaceutical worker.

PMID: 20442121
Journal: CHEST
Year: 2010
Reference: Chest. 2010 May;137(5):1200-2.
Impact factor:
Publication type: Paper in international publication
Authors: Cruz, Maria-Jesus; Gomez-Olles, Susana; Madrid-San Martin, Federico; Munoz, Xavier et al.
DOI: 10.1378/chest.09-1881

Off-label use of rituximab in 196 patients with severe, refractory systemic autoimmune diseases.

PMID: 20525449
Journal: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
Year: 2010
Reference: Clin Exp Rheumatol. 2010 Jul-Aug;28(4):468-76. Epub 2010 Aug 30.
Impact factor: 2.396
Publication type: Paper in international publication
Authors: , , , , , , , , , et al.
DOI:

Off-label use of rituximab in 196 patients with severe, refractory systemic autoimmune diseases.

PMID: 20525449
Journal: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
Year: 2010
Reference: Clin Exp Rheumatol. 2010 Jul-Aug;28(4):468-76. Epub 2010 Aug 30.
Impact factor:
Publication type: Paper in international publication
Authors: ; ; ; ; ; ; ; ; ; et al.
DOI:

[On the way to shortening tuberculosis treatments: clinical trials of the Unitat d' Investagacio en Tuberculosi de Barcelona supported by the Centers for Disease Control and Prevention]

PMID: 20005019
Journal: Gaceta Sanitaria
Year: 2010
Reference: Gac Sanit. 2010 Mar-Apr;24(2):171.e1-6. Epub 2009 Dec 10.
Impact factor: 1.172
Publication type: Paper in national publication
Authors: Moreno, Antonio, Sanchez, Francesca, Nelson, Jeanne, Miro, Jose M, Cayla, Joan A, Alcaide Fernandez de Vega, Fernando, Altet, Neus, Cantos, Adela, Cayla, Joan A, Coll, Pere et al.
DOI: 10.1016/j.gaceta.2009.08.008

[On the way to shortening tuberculosis treatments: clinical trials of the Unitat d' Investagacio en Tuberculosi de Barcelona supported by the Centers for Disease Control and Prevention]

PMID: 20005019
Journal: Gaceta Sanitaria
Year: 2010
Reference: Gac Sanit. 2010 Mar-Apr;24(2):171.e1-6. Epub 2009 Dec 10.
Impact factor:
Publication type: Paper in national publication
Authors: Alcaide Fernandez de Vega, Fernando; Altet, Neus; Cantos, Adela; Cayla, Joan A; Cayla, Joan A; Coll, Pere; Cuchi, Eva; Falco, Vicenc; Font Canals, M Roser; Garcia, Laura et al.
DOI: 10.1016/j.gaceta.2009.08.008

Once-daily prolonged-release tacrolimus (ADVAGRAF) versus twice-daily tacrolimus (PROGRAF) in liver transplantation.

PMID: 20840481
Journal: AMERICAN JOURNAL OF TRANSPLANTATION
Year: 2010
Reference: Am J Transplant. 2010 Oct;10(10):2313-23. doi: 10.1111/j.1600-6143.2010.03255.x. Epub 2010 Sep 14.
Impact factor: 6.433
Publication type: Paper in international publication
Authors: Fischer, L, Baccarani, U, Ortiz de Urbina, J, Wall, W, McCaughan, G, Jones, R, Troisi, R I, De Roover, A, Mies, S, Moreira, L et al.
DOI: 10.1111/j.1600-6143.2010.03255.x

Once-daily prolonged-release tacrolimus (ADVAGRAF) versus twice-daily tacrolimus (PROGRAF) in liver transplantation.

PMID: 20840481
Journal: AMERICAN JOURNAL OF TRANSPLANTATION
Year: 2010
Reference: Am J Transplant. 2010 Oct;10(10):2313-23. doi: 10.1111/j.1600-6143.2010.03255.x. Epub 2010 Sep 14.
Impact factor:
Publication type: Paper in international publication
Authors: Baccarani, U; Baccarani, U; Backman, L; Bentdal, O; Bernardos, A; Bilbao, I; Boillot, O; Boillot, O; Boudjema, K; Burroughs, A et al.
DOI: 10.1111/j.1600-6143.2010.03255.x

Open-Label, Phase II, Multicenter, Randomized Study of the Efficacy and Safety of Two Dose Levels of Pertuzumab, a Human Epidermal Growth Factor Receptor 2 Dimerization Inhibitor, in Patients With Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer.

PMID: 20124183
Journal: JOURNAL OF CLINICAL ONCOLOGY
Year: 2010
Reference: J Clin Oncol. 2010 Mar 1;28(7):1131-7. Epub 2010 Feb 1.
Impact factor: 17.793
Publication type: Paper in international publication
Authors: , , , , , , , , , et al.
DOI: 10.1200/JCO.2009.24.1661

Open-Label, Phase II, Multicenter, Randomized Study of the Efficacy and Safety of Two Dose Levels of Pertuzumab, a Human Epidermal Growth Factor Receptor 2 Dimerization Inhibitor, in Patients With Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer.

PMID: 20124183
Journal: JOURNAL OF CLINICAL ONCOLOGY
Year: 2010
Reference: J Clin Oncol. 2010 Mar 1;28(7):1131-7. Epub 2010 Feb 1.
Impact factor:
Publication type: Paper in international publication
Authors: ; ; ; ; ; ; ; ; ; et al.
DOI: 10.1200/JCO.2009.24.1661

Optimization of Liver Transplantation as a Treatment of Intrahepatic Hepatocellular Carcinoma Recurrence After Partial Liver Resection: Experience of a Single European Series.

PMID: 20411387
Journal: WORLD JOURNAL OF SURGERY
Year: 2010
Reference: World J Surg. 2010 Sep;34(9):2146-54.
Impact factor: 2.696
Publication type: Paper in international publication
Authors: , , , , , , , , et al.
DOI: 10.1007/s00268-010-0583-4

Optimization of Liver Transplantation as a Treatment of Intrahepatic Hepatocellular Carcinoma Recurrence After Partial Liver Resection: Experience of a Single European Series.

PMID: 20411387
Journal: WORLD JOURNAL OF SURGERY
Year: 2010
Reference: World J Surg. 2010 Sep;34(9):2146-54.
Impact factor:
Publication type: Paper in international publication
Authors: ; ; ; ; ; ; ; ; et al.
DOI: 10.1007/s00268-010-0583-4

Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis.

PMID: 20089954
Journal: NEW ENGLAND JOURNAL OF MEDICINE
Year: 2010
Reference: N Engl J Med. 2010 Feb 4;362(5):402-15. Epub 2010 Jan 20.
Impact factor: 47.05
Publication type: Paper in international publication
Authors: , , , , , , , , , et al.
DOI: 10.1056/NEJMoa0907839

Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis.

PMID: 20089954
Journal: NEW ENGLAND JOURNAL OF MEDICINE
Year: 2010
Reference: N Engl J Med. 2010 Feb 4;362(5):402-15. Epub 2010 Jan 20.
Impact factor:
Publication type: Paper in international publication
Authors: ; ; ; ; ; ; ; ; ; et al.
DOI: 10.1056/NEJMoa0907839

[Oral hygiene with chlorhexidine on the prevention of ventilator-associated pneumonia in intubated patients: A systematic review of randomized clinical trials.]

PMID: 20557902
Journal: MEDICINA CLINICA
Year: 2010
Reference: Med Clin (Barc). 2010 Oct 9;135(11):491-7. Epub 2010 Jun 16.
Impact factor: 1.231
Publication type: Paper in national publication
Authors: , , , , , et al.
DOI: 10.1016/j.medcli.2010.02.039

[Oral hygiene with chlorhexidine on the prevention of ventilator-associated pneumonia in intubated patients: A systematic review of randomized clinical trials.]

PMID: 20557902
Journal: MEDICINA CLINICA
Year: 2010
Reference: Med Clin (Barc). 2010 Oct 9;135(11):491-7. Epub 2010 Jun 16.
Impact factor:
Publication type: Paper in national publication
Authors: ; ; ; ; ; et al.
DOI: 10.1016/j.medcli.2010.02.039

Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled study.

PMID: 20834039
Journal: MULTIPLE SCLEROSIS
Year: 2010
Reference: Mult Scler. 2010 Nov;16(11):1360-6. Epub 2010 Sep 8.
Impact factor: 3.279
Publication type: Paper in international publication
Authors: Tumani, H, Abramsky, O, Arbizu, T, Boyko, A, Gold, R, Havrdova, E, Komoly, S, Selmaj, K, Sharrack, B, Filippi, M et al.
DOI: 10.1177/1352458510378127

Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled study.

PMID: 20834039
Journal: MULTIPLE SCLEROSIS
Year: 2010
Reference: Mult Scler. 2010 Nov;16(11):1360-6. Epub 2010 Sep 8.
Impact factor:
Publication type: Paper in international publication
Authors: Abramsky, O; Abramsky, O; Antiguedad, A R; Arbizu, T; Arbizu, T; Arbizu, T; Arroyo, R; Barcena, J; Bartos, L; Bertolotto, A et al.
DOI: 10.1177/1352458510378127

Publications

Publications searcher

Nurses' knowledge of evidence-based guidelines for the prevention of surgical site infection.

Nurses' knowledge of evidence-based guidelines for the prevention of surgical site infection.

[Nursing role in patient management diagnosed chronic fatigue syndrome].

[Nursing role in patient management diagnosed chronic fatigue syndrome].

Obstructive sleep apnoea and 24-h blood pressure in patients with resistant hypertension.

Obstructive sleep apnoea and 24-h blood pressure in patients with resistant hypertension.

Occupational asthma due to colistin in a pharmaceutical worker.

Occupational asthma due to colistin in a pharmaceutical worker.

Off-label use of rituximab in 196 patients with severe, refractory systemic autoimmune diseases.

Off-label use of rituximab in 196 patients with severe, refractory systemic autoimmune diseases.

[On the way to shortening tuberculosis treatments: clinical trials of the Unitat d' Investagacio en Tuberculosi de Barcelona supported by the Centers for Disease Control and Prevention]

[On the way to shortening tuberculosis treatments: clinical trials of the Unitat d' Investagacio en Tuberculosi de Barcelona supported by the Centers for Disease Control and Prevention]

Once-daily prolonged-release tacrolimus (ADVAGRAF) versus twice-daily tacrolimus (PROGRAF) in liver transplantation.

Once-daily prolonged-release tacrolimus (ADVAGRAF) versus twice-daily tacrolimus (PROGRAF) in liver transplantation.

Open-Label, Phase II, Multicenter, Randomized Study of the Efficacy and Safety of Two Dose Levels of Pertuzumab, a Human Epidermal Growth Factor Receptor 2 Dimerization Inhibitor, in Patients With Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer.

Open-Label, Phase II, Multicenter, Randomized Study of the Efficacy and Safety of Two Dose Levels of Pertuzumab, a Human Epidermal Growth Factor Receptor 2 Dimerization Inhibitor, in Patients With Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer.

Optimization of Liver Transplantation as a Treatment of Intrahepatic Hepatocellular Carcinoma Recurrence After Partial Liver Resection: Experience of a Single European Series.

Optimization of Liver Transplantation as a Treatment of Intrahepatic Hepatocellular Carcinoma Recurrence After Partial Liver Resection: Experience of a Single European Series.

Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis.

Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis.

[Oral hygiene with chlorhexidine on the prevention of ventilator-associated pneumonia in intubated patients: A systematic review of randomized clinical trials.]

[Oral hygiene with chlorhexidine on the prevention of ventilator-associated pneumonia in intubated patients: A systematic review of randomized clinical trials.]

Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled study.

Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled study.

Patronage:

Collaborating:

Accreditations: